HuGE Literature Finder
Records
1
-
30
| Recurrence-associated gene signature in patients with stage I non-small-cell lung cancer. Scientific reports 2021 Oct 11 (1): 19596. Cho Su Han, Yoon Shinkyo, Lee Dae Ho, Kim Sang-We, Kim Kwone |
| Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study. Cancer cell 2021 Jul . Zhou Qing, Xu Chong-Rui, Cheng Ying, Liu Yun-Peng, Chen Gong-Yan, Cui Jiu-Wei, Yang Nong, Song Yong, Li Xiao-Ling, Lu Shun, Zhou Jian-Ying, Ma Zhi-Yong, Yu Shi-Ying, Huang Cheng, Shu Yong-Qian, Wang Zhen, Yang Jin-Ji, Tu Hai-Yan, Zhong Wen-Zhao, Wu Yi-Lo |
| Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study. Frontiers in oncology 2021 11 695038. Jantus-Lewintre Eloisa, Massutí Sureda Bartomeu, González Larriba José Luis, Rodríguez-Abreu Delvys, Juan Oscar, Blasco Ana, Dómine Manuel, Provencio Pulla Mariano, Garde Javier, Álvarez Rosa, Maestu Inmaculada, Pérez de Carrión Ramón, Artal Ángel, Rolfo Christian, de Castro Javier, Guillot Mónica, Oramas Juana, de Las Peñas Ramón, Ferrera Lioba, Martínez Natividad, Serra Òlbia, Rosell Rafael, Camps Carl |
| Erlotinib plus bevacizumab vs erlotinib monotherapy as first-line treatment for advanced EGFR mutation-positive non-squamous non-small-cell lung cancer: Survival follow-up results of the randomized JO25567 study. Lung cancer (Amsterdam, Netherlands) 2020 Nov 151 20-24. Yamamoto N, Seto T, Nishio M, Goto K, Yamamoto N, Okamoto I, Yamanaka T, Tanaka M, Takahashi K, Fukuoka |
| Combined Inhibition of EGFR and VEGF Pathways in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Current oncology reports 2020 Sep 22 (12): 119. Peravali Monica, Wang Haijun, Kim Chul, Veytsman Iri |
| First-line angiogenesis inhibitor plus erlotinib versus erlotinib alone for advanced non-small-cell lung cancer harboring an EGFR mutation. Journal of cancer research and clinical oncology 2020 Jul . Landre Thierry, Des Guetz Gaetan, Chouahnia Kader, Duchemann Boris, Assié Jean-Baptiste, Chouaid Christ |
| Correlation of gene polymorphisms of vascular endothelial growth factor with grade and prognosis of lung cancer. BMC medical genetics 2020 Apr 21 (1): 86. Liu Changjiang, Zhou Xuetao, Zhang Zefeng, Guo Ya |
| Efficacy and safety of erlotinib combined with bevacizumab in the treatment of non-small cell lung cancer: A systematic review and meta-analysis. Medicine 2020 Jan 99 (3): e18771. Zhou Kenan, Zhao Shishun, Guo Wenlai, Ding L |
| Relationship between vascular endothelial growth factor -2578C > a gene polymorphism and lung cancer risk: a meta-analysis. BMC medical genetics 2020 Jan 21 (1): 17. Zhao Hui-Liu, Yu Jia-Hua, Huang Ling-Sha, Li Pei-Zhang, Lao Ming, Zhu Bo, Ou Ch |
| Differential Efficacy of Anti-VEGF Antibodies Based on Sex and Race in a Diverse Cohort of Advanced Nonsquamous Non-Small Cell Lung Cancer. American journal of clinical oncology 2019 Nov . Sukrithan Vineeth, Barbaro Alexander, Chergui Adel, Ko Brian, Lin Juan, Cheng Haiying, Goel Sanj |
| Prognostic effect of VEGF gene variants in metastatic non-small-cell lung cancer patients. Angiogenesis 2019 Apr . Sullivan Ivana, Riera Pau, Andrés Marta, Altés Albert, Majem Margarita, Blanco Remei, Capdevila Laia, Barba Andrés, Barnadas Agustí, Salazar Julia |
| Association between EGFR/KRAS mutation and expression of VEGFA, VEGFR and VEGFR2 in lung adenocarcinoma. Oncology letters 2018 Aug 16 (2): 2105-2112. Yuan Xiao-Han, Yang Jie, Wang Xin-Yue, Zhang Xiao-Ling, Qin Ting-Ting, Li K |
| Association between VEGF Gene Polymorphisms and the Susceptibility to Lung Cancer: An Updated Meta-Analysis. BioMed research international 2018 2018 9271215. Yang Fengming, Qin Zhiqiang, Shao Chuchu, Liu Weitao, Ma Ling, Shu Yongqian, Shen H |
| KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2017 Feb . Sullivan I, Salazar J, Arqueros C, Andrés M, Sebio A, Majem M, Szafranska J, Martínez E, Páez D, López-Pousa A, Baiget M, Barnadas |
| Single nucleotide polymorphisms, haplotype association and tumour expression of the vascular endothelial growth factor (VEGF) gene with lung carcinoma. Gene 2017 Jan . Naykoo Niyaz A, Dil-Afroze , Rasool Roohi, Shah Sonaullah, Ahangar A G, Bhat Imtiyaz A, Qasim Iqbal, Siddiqi Mushtaq A, Shah Zafar |
| SNP and Haplotype Analysis of Vascular Endothelial Growth Factor (VEGF) Gene in Lung Cancer Patients of Kashmir Asian Pacific journal of cancer prevention : APJCP 2017 07 18 (7): 1799-1804. Naikoo Niyaz A, Afroze Dil, Rasool Roohi, Shah Sonaullah, Ahangar A G, Bhat Imtiyaz A, Qasim Iqbal, Siddiqi Mushtaq A, Shah Zafar |
| Effect of Combined Therapy Inhibiting EGFR and VEGFR Pathways in Non-Small-cell Lung Cancer on Progression-free and Overall Survival. Clinical lung cancer 2016 Dec . Jiang Tao, Qiao Meng, Zhou Fei, Ren Shengxiang, Su Chunxia, Zhou Caic |
| The Different Effect of VEGF Polymorphisms on the Prognosis of Non-Small Cell Lung Cancer according to Tumor Histology. Journal of Korean medical science 2016 Nov 31 (11): 1735-1741. Lee Soyeon, Kang Hyo Gyoung, Choi Jin Eun, Lee Jang Hyuck, Kang Hyo Jung, Baek Sun Ah, Lee Eungbae, Seok Yangki, Lee Won Kee, Lee Shin Yup, Yoo Seung Soo, Lee Jaehee, Cha Seung Ick, Kim Chang Ho, Cho Sukki, Park Jae Yo |
| The VEGFR2, COX-2 and MMP-2 polymorphisms are associated with clinical outcome of patients with inoperable non-small cell lung cancer. International journal of cancer. Journal international du cancer 2015 Nov 137 (10): 2332-42. Butkiewicz Dorota, Krze?niak Ma?gorzata, Drosik Anna, Giglok Monika, Gdowicz-K?osok Agnieszka, Kosarewicz Agata, Rusin Marek, Mas?yk Barbara, Gawkowska-Suwi?ska Marzena, Suwi?ski Raf |
| Role of vascular endothelial growth factor in non-small cell lung cancer pathogenesis. Experimental oncology 2015 Sep 37 (3): 213-7. Krupnova E V, Shapetska M N, Mikhalenko E P, Chebotaryova N V, Shchayuk A N, Pissarchik S N, Prokhorov A |
| Correlation of genetic polymorphism of vascular endothelial growth factor gene with susceptibility to lung cancer. Cancer gene therapy 2015 Jun 22 (6): 312-6. Liu C, Zhou X, Gao F, Qi Z, Zhang Z, Guo |
| Role of VEGF gene polymorphisms in the clinical outcome of non-small cell lung cancer. Genetics and molecular research : GMR 2015 14 (4): 16006-11. Chen N, Ma C N, Zhao M, Zhang Y |
| Vascular endothelial growth factor polymorphisms and lung cancer risk. International journal of clinical and experimental medicine 2015 8 (4): 6406-11. Fan Junli, Zhang Weiguo, Lei Caipeng, Qiao Bin, Liu Qin, Chen Qiang, Jiao Hongduo, Jiang Leizhen, Cui Shuo, Chen Jianm |
| Association of the vascular endothelial growth factor -2578C/A polymorphism with cancer risk: A meta-analysis update. Biomedical reports 2014 Nov 2 (6): 823-830. Chen Quanchi, Zhou Zifei, Shan Liangcheng, Hua Yingqi, Zeng Hui, Liu Pengcheng, Cai Zhengdo |
| Vascular endothelial growth factor -634G/C and vascular endothelial growth factor -2578C/A polymorphisms and lung cancer risk: a case-control study and meta-analysis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Mar 35 (3): 1805-11. Deng Zai-Chun, Cao Chao, Yu Yi-Ming, Ma Hong-Ying, Ye Me |
| Vascular endothelial growth factor (VEGF) -2578C/A and -460C/T gene polymorphisms and lung cancer risk: a meta-analysis involving 11 case-control studies. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Jan 35 (1): 859-70. Song Ning, Liu Bao, Wu Jianling, Zhang Rufang, Duan Lin, He Wenshu, Zhang Congm |
| Association between +936 C>T gene polymorphism of vascular endothelial growth factor and lung cancer: a meta-analysis. Cancer biomarkers : section A of Disease markers 2014 14 (6): 483-92. Yu Wanjia, Jiang Xueyan, Bai Tuya, Lv Xiaoli, Chang Fuh |
| rs833061 and rs699947 on promoter gene of vascular endothelial growth factor (VEGF) and associated lung cancer susceptibility and survival: a meta-analysis. Medical science monitor : international medical journal of experimental and clinical research 2014 20 2520-6. Tu Junwei, Wang Saibin, Zhao Jianping, Zhu Jingqian, Sheng Lin, Sheng Yijun, Chen Huijun, Tian Jiangh |
| Four common vascular endothelial growth factor polymorphisms (-2578C>A, -460C>T, +936C>T, and +405G>C) in susceptibility to lung cancer: a meta-analysis. PloS one 2013 8 (10): e75123. Lin Ling, Cao Kejian, Chen Wenhu, Pan Xufeng, Zhao He |
| The impact of polymorphic variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the risk and prognosis of portuguese patients with non-small cell lung cancer. PloS one 2013 8 (9): e72373. de Mello Ramon Andrade, Ferreira Mónica, Soares-Pires Filipa, Costa Sandra, Cunha João, Oliveira Pedro, Hespanhol Venceslau, Reis Rui Manu |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 16, 2022
- Content source: